UA76410C2 - Azaindols, pharmaceutical composition on their basis - Google Patents

Azaindols, pharmaceutical composition on their basis Download PDF

Info

Publication number
UA76410C2
UA76410C2 UA2002076056A UA2002076056A UA76410C2 UA 76410 C2 UA76410 C2 UA 76410C2 UA 2002076056 A UA2002076056 A UA 2002076056A UA 2002076056 A UA2002076056 A UA 2002076056A UA 76410 C2 UA76410 C2 UA 76410C2
Authority
UA
Ukraine
Prior art keywords
group
compound according
vya
iia
optionally substituted
Prior art date
Application number
UA2002076056A
Other languages
English (en)
Ukrainian (uk)
Inventor
Justine Yeun Quai Lai
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Priority claimed from PCT/GB2000/004993 external-priority patent/WO2001047922A2/en
Publication of UA76410C2 publication Critical patent/UA76410C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UA2002076056A 1999-12-24 2000-12-27 Azaindols, pharmaceutical composition on their basis UA76410C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930698.7A GB9930698D0 (en) 1999-12-24 1999-12-24 Chemical compounds
PCT/GB2000/004993 WO2001047922A2 (en) 1999-12-24 2000-12-27 Azaindoles

Publications (1)

Publication Number Publication Date
UA76410C2 true UA76410C2 (en) 2006-08-15

Family

ID=10867079

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002076056A UA76410C2 (en) 1999-12-24 2000-12-27 Azaindols, pharmaceutical composition on their basis

Country Status (12)

Country Link
JP (1) JP4871474B2 (de)
AT (2) ATE552258T1 (de)
DE (1) DE60044946D1 (de)
DK (2) DK1990343T3 (de)
ES (2) ES2348861T3 (de)
GB (1) GB9930698D0 (de)
ME (1) MEP49908A (de)
PL (1) PL218884B1 (de)
PT (2) PT1263759E (de)
RS (2) RS20100123A (de)
UA (1) UA76410C2 (de)
ZA (1) ZA200204126B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422057D0 (en) * 2004-10-05 2004-11-03 Astrazeneca Ab Novel compounds
SI1962830T1 (sl) * 2005-12-23 2013-07-31 Glaxosmithkline Llc Azaindolni inhibitorji kinaz Aurora
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
JP5274805B2 (ja) * 2006-09-20 2013-08-28 三菱化学株式会社 フッ素化芳香族化合物の製造方法
KR101361858B1 (ko) * 2008-12-05 2014-02-12 에프. 호프만-라 로슈 아게 피롤로피라지닐 우레아 키나아제 저해제
US8816085B2 (en) * 2009-08-26 2014-08-26 Takeda Gmbh Methylpyrrolopyridinecarboxamides
MX2015012899A (es) * 2013-03-14 2016-06-02 Abbvie Inc Pirrolo [2,3-b] piridina como inhibidores de quinasa cdk9.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69728688T2 (de) * 1996-11-19 2004-08-19 Amgen Inc., Thousand Oaks Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel
AU7132998A (en) * 1997-04-24 1998-11-13 Ortho-Mcneil Corporation, Inc. Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
ES2221213T3 (es) * 1997-10-20 2004-12-16 F. Hoffmann-La Roche Ag Inhibidores de kinasa biciclicos.

Also Published As

Publication number Publication date
ZA200204126B (en) 2003-08-25
ES2348861T3 (es) 2010-12-16
JP4871474B2 (ja) 2012-02-08
DE60044946D1 (de) 2010-10-21
ATE480537T1 (de) 2010-09-15
RS51303B (sr) 2010-12-31
ATE552258T1 (de) 2012-04-15
DK1263759T3 (da) 2011-01-10
PL218884B1 (pl) 2015-02-27
PT1990343E (pt) 2012-05-22
ES2382759T3 (es) 2012-06-13
MEP49908A (en) 2011-02-10
GB9930698D0 (en) 2000-02-16
PT1263759E (pt) 2010-11-02
YU46202A (sh) 2005-06-10
RS20100123A (sr) 2010-12-31
DK1990343T3 (da) 2012-07-23
JP2003519144A (ja) 2003-06-17

Similar Documents

Publication Publication Date Title
JP5436507B2 (ja) アザインドール
EP2324024B1 (de) Diazacarbazole und anwendungsverfahren
RS57838B1 (sr) Arilhinazolini
CN111303159A (zh) 用于治疗由布鲁顿酪氨酸激酶(btk)介导的疾病的吡唑甲酰胺化合物
TWI732249B (zh) Fgfr抑制劑、其製備方法和應用
UA76410C2 (en) Azaindols, pharmaceutical composition on their basis
CN120500480A (zh) 治疗癌症的方法
CN116283960A (zh) 取代的稠杂环化合物及其制备方法与应用
HK40091719A (zh) 取代的稠杂环化合物及其制备方法与应用
HK40091719B (zh) 取代的稠杂环化合物及其制备方法与应用
HK40030138A (en) Pyrazole carboxamide compounds for use in the treament of disorders mediated by bruton's tyrosine kinase (btk)
HK1235057B (zh) 用於治疗由布鲁顿酪氨酸激酶(btk)介导的疾病的吡唑甲酰胺化合物